Persistent Left Atrial Appendage Thrombus in Atrial Fibrillation Despite Anticoagulation
Journal of Cardiovascular Electrophysiology · 2025
DOI: 10.1111/jce.16718 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2025. Verfasst von Alexander Kushnir und 10 weiteren Autor:innen. Beteiligte Einrichtung: Leon H. Charney Division of Cardiology, Cardiac Electrophysiology, NYU Langone Health, New York University Grossman School of Medicine, New York, New…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Atrial Appendage, Anticoagulants, Thrombosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Objectives
Assess the characteristics and management of patients with LAA thrombus despite compliance with oral anticoagulation (OAC).
Background
Atrial fibrillation guidelines consider 4 weeks of uninterrupted OAC sufficient to avoid transesophageal echocardiography to rule out left atrial appendage thrombus. However, some patients may exhibit persistent thrombus despite compliance with OAC.
Methods
Clinical history, management, and outcomes were reviewed for patients with LAA thrombus on preprocedural TEE presenting for an AF related procedure between 2021 and 2024.
Results
Sixty‐five (1.8%) of 3653 preprocedural TEEs exhibited LAA thrombus. OAC compliance of at least 4 week was documented in 39 (60%) of these patients, including Apixaban 64%, Rivaroxaban 23%, Warfarin 8%, Dabigatran 5%. Two of these patients (3%) experienced an embolic event and 8 (12%) died during the follow up period. Resolution of LAA thrombus was documented in 12/32 patients, 6 who switched to Dabigatran, 2 to Eliquis, 1 to Warfarin, and 3 remained on Eliquis. LAA‐occlusion was successfully performed in seven patients with persistent LAA thrombus. CHADS‐VASc 3 or greater, HFrEF, or valvular AF were present in 37/39 of these patients.
Conclusion
For 3653 patients who underwent Preprocedural TEE, 39 exhibited LAA thrombus despite compliance with OAC. Switching OAC or maintaining the same agent for longer period of time resolved the thrombus in 31% of cases. LAA‐O was effective in cases where the thrombus did not resolve. Patients with non‐valvular AF, compliance with OAC > 4 weeks, CHADS‐VASc ≤ 2, and normal EF exhibited the lowest probability for not having a thrombus on TEE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Leon H. Charney Division of Cardiology, Cardiac Electrophysiology, NYU Langone Health, New York University Grossman School of Medicine, New York, New York, USA.
ORCID-Profile: Anthony Aizer, Larry A Chinitz
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Kushnir, A., Bernstein, S., Barbhaiya, C. R., Jankelson, L., Holmes, D., Aizer, A., Park, D., Spinelli, M., Garber, L., Yang, F., & Chinitz, L. A. (2025). Persistent Left Atrial Appendage Thrombus in Atrial Fibrillation Despite Anticoagulation. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.16718
Vancouver
Kushnir A, Bernstein S, Barbhaiya CR, Jankelson L, Holmes D, Aizer A, et al. Persistent Left Atrial Appendage Thrombus in Atrial Fibrillation Despite Anticoagulation. Journal of Cardiovascular Electrophysiology. 2025. doi:10.1111/jce.16718
BibTeX
@article{Kushnir2025,
author = {Kushnir, Alexander and Bernstein, Scott and Barbhaiya, Chirag R and Jankelson, Lior and Holmes, Douglas and Aizer, Anthony and Park, David and Spinelli, Michael and Garber, Leonard and Yang, Felix and Chinitz, Larry A},
title = {Persistent Left Atrial Appendage Thrombus in Atrial Fibrillation Despite Anticoagulation},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2025},
doi = {10.1111/jce.16718}
}
EUVIMED